Yahoo FinanceDirector Share Purchase
Arix Bioscience PLC (ARIX) Arix Bioscience plcDirector Share Purchase
LONDON, 21 December 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Naseem Amin, Executive Chairman, purchased 183,000 ordinary shares ("Ordinary Shares") in the Company on 18 December 2020 at a price of 206p per share, via a corporate entity in which he has a majority beneficial interest.
The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the transaction in number of Ordinary Shares.
For further information:
Robert Lyne Chief Operating Officer and General Counsel +44 (0)207 290 1050
- Ends - | PDMR DEALING NOTIFICATION | Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them | 1 | Details of the person discharging managerial responsibilities / person closely associated | a) | Name | Naseem Amin | 2 | Reason for the notification | a) | Position / status | Executive Chairman | b) | Initial notification / Amendment | Initial Notification | 3 | Details of issuer | a) | Name | Arix Bioscience plc | b) | LEI | 213800OVT3AHQCXNIX43 | 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) | Description of the financial instrument, type of instrument | Ordinary Shares of Arix Bioscience plc | Identification code | GB00BD045071 | b) | Nature of the transaction | Purchase of Ordinary Shares by Davum Capital Limited, a corporate entity in which Naseem Amin has a majority beneficial interest | c) | Price(s) and volume(s) | Price(s) | Volume(s) | 206.00p | 183,000 | d) | Aggregated information | Aggregated price | Aggregated volume | N/A (single transaction) | N/A (single transaction) | e) | Date of the transaction | 18 December 2020 | f) | Place of the transaction | London Stock Exchange (XLON) |
PDMR DEALING NOTIFICATION | |||||||||||||||||||||||||||||||||||||||||||||||||||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them | |||||||||||||||||||||||||||||||||||||||||||||||||||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||||||||||||||||||||||||||||||||||||||||||||||||
a) | Name | Naseem Amin | |||||||||||||||||||||||||||||||||||||||||||||||||
2 | Reason for the notification | ||||||||||||||||||||||||||||||||||||||||||||||||||
a) | Position / status | Executive Chairman | |||||||||||||||||||||||||||||||||||||||||||||||||
b) | Initial notification / Amendment | Initial Notification | |||||||||||||||||||||||||||||||||||||||||||||||||
3 | Details of issuer | ||||||||||||||||||||||||||||||||||||||||||||||||||
a) | Name | Arix Bioscience plc | |||||||||||||||||||||||||||||||||||||||||||||||||
b) | LEI | 213800OVT3AHQCXNIX43 | |||||||||||||||||||||||||||||||||||||||||||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||||||||||||||||||||||||||||||||||||||||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of Arix Bioscience plc | |||||||||||||||||||||||||||||||||||||||||||||||||
Identification code | GB00BD045071 | ||||||||||||||||||||||||||||||||||||||||||||||||||
b) | Nature of the transaction | Purchase of Ordinary Shares by Davum Capital Limited, a corporate entity in which Naseem Amin has a majority beneficial interest | |||||||||||||||||||||||||||||||||||||||||||||||||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||||||||||||||||||||||||||||||||||||||||||||||||
206.00p | 183,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
d) | Aggregated information | Aggregated price | Aggregated volume | ||||||||||||||||||||||||||||||||||||||||||||||||
N/A (single transaction) | N/A (single transaction) | ||||||||||||||||||||||||||||||||||||||||||||||||||
e) | Date of the transaction | 18 December 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||
f) | Place of the transaction | London Stock Exchange (XLON) |
ISIN: | GB00BD045071 |
Category Code: | DSH |
TIDM: | ARIX |
LEI Code: | 213800OVT3AHQCXNIX43 |
Sequence No.: | 90018 |
EQS News ID: | 1156507 |
| |
End of Announcement | EQS News Service |
